ARCUTIS BIOTHERAPEUTICS INC (ARQT) Stock Analyst Ratings
NASDAQ:ARQT • US03969K1088
26.97 USD
-1.6 (-5.6%)
At close: Feb 27, 2026
26.7 USD
-0.27 (-1%)
After Hours: 2/27/2026, 8:00:02 PM
ChartMill assigns a Buy % Consensus number of 83% to ARQT. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 32.39. This target is 20.08% above the current price.
- ARQT was analyzed by 14 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ARQT.
- In the previous month the buy percentage consensus was at a similar level.
- ARQT was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-27 | Guggenheim | Maintains | Buy -> Buy |
| 2026-02-26 | TD Cowen | Maintains | Buy -> Buy |
| 2026-02-26 | Needham | Maintains | Buy -> Buy |
| 2026-02-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-26 | Needham | Maintains | Buy -> Buy |
| 2025-11-28 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-30 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-10-28 | Needham | Maintains | Buy -> Buy |
| 2025-08-07 | Needham | Maintains | Buy -> Buy |
| 2025-07-25 | Goldman Sachs | Initiate | Neutral |
| 2025-05-23 | Needham | Reiterate | Buy -> Buy |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-04-03 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-03 | Needham | Reiterate | Buy -> Buy |
| 2025-04-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-11 | Jefferies | Maintains | Buy -> Buy |
| 2025-02-27 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-02-26 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-02-26 | Needham | Reiterate | Buy -> Buy |
| 2025-02-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-24 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-02-10 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-07 | Mizuho | Maintains | Outperform -> Outperform |
| 2024-12-30 | HC Wainwright & Co. | Initiate | Buy |
| 2024-11-07 | Needham | Reiterate | Buy -> Buy |
| 2024-08-28 | Jefferies | Initiate | Buy |
| 2024-08-15 | Needham | Reiterate | Buy -> Buy |
| 2024-07-30 | Needham | Reiterate | Buy -> Buy |
| 2024-07-10 | Needham | Reiterate | Buy -> Buy |
ARCUTIS BIOTHERAPEUTICS INC / ARQT FAQ
What is the average price target for ARCUTIS BIOTHERAPEUTICS INC (ARQT) stock?
14 analysts have analysed ARQT and the average price target is 32.39 USD. This implies a price increase of 20.08% is expected in the next year compared to the current price of 26.97.
What is the consensus rating for ARQT stock?
The consensus rating for ARCUTIS BIOTHERAPEUTICS INC (ARQT) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for ARQT stock?
The number of analysts covering ARCUTIS BIOTHERAPEUTICS INC (ARQT) is 14.